US 6686333
Inhibition of HIV replication using soluble Tat peptide analogs
expired A61KA61K38/00
Quick answer
US patent 6686333 (Inhibition of HIV replication using soluble Tat peptide analogs) held by The United States of America as represented by the Department of Health and Human Resources expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as represented by the Department of Health and Human Resources
- Grant date
- Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00